Veeva Systems Price to Free Cash Flow Ratio 2012-2025 | VEEV
Veeva Systems Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2025-04-29 | 231.64 | 35.79 | |
2025-01-31 | 233.26 | $6.47 | 36.04 |
2024-10-31 | 208.83 | $6.40 | 32.61 |
2024-07-31 | 191.93 | $5.90 | 32.51 |
2024-04-30 | 198.56 | $6.91 | 28.73 |
2024-01-31 | 207.41 | $5.41 | 38.31 |
2023-10-31 | 192.71 | $5.46 | 35.28 |
2023-07-31 | 204.22 | $5.85 | 34.92 |
2023-04-30 | 179.08 | $4.86 | 36.85 |
2023-01-31 | 170.55 | $4.72 | 36.12 |
2022-10-31 | 167.94 | $4.69 | 35.82 |
2022-07-31 | 223.58 | $4.52 | 49.47 |
2022-04-30 | 181.95 | $4.65 | 39.16 |
2022-01-31 | 236.54 | $4.62 | 51.16 |
2021-10-31 | 317.01 | $4.74 | 66.94 |
2021-07-31 | 332.71 | $4.62 | 72.02 |
2021-04-30 | 282.45 | $4.54 | 62.25 |
2021-01-31 | 276.44 | $3.38 | 81.89 |
2020-10-31 | 270.05 | $3.19 | 84.72 |
2020-07-31 | 264.57 | $3.01 | 87.91 |
2020-04-30 | 190.80 | $3.02 | 63.16 |
2020-01-31 | 146.61 | $2.74 | 53.59 |
2019-10-31 | 141.83 | $2.66 | 53.23 |
2019-07-31 | 165.90 | $2.52 | 65.93 |
2019-04-30 | 139.87 | $2.45 | 57.13 |
2019-01-31 | 109.06 | $1.93 | 56.56 |
2018-10-31 | 91.35 | $1.75 | 52.25 |
2018-07-31 | 75.63 | $1.71 | 44.23 |
2018-04-30 | 70.13 | $1.50 | 46.72 |
2018-01-31 | 62.86 | $1.45 | 43.50 |
2017-10-31 | 60.94 | $1.41 | 43.28 |
2017-07-31 | 63.76 | $1.37 | 46.42 |
2017-04-30 | 53.62 | $1.10 | 48.78 |
2017-01-31 | 42.33 | $0.93 | 45.76 |
2016-10-31 | 38.85 | $0.97 | 40.16 |
2016-07-31 | 37.99 | $0.91 | 41.57 |
2016-04-30 | 27.51 | $0.88 | 31.14 |
2016-01-31 | 24.10 | $0.40 | 59.65 |
2015-10-31 | 25.37 | $0.38 | 66.33 |
2015-07-31 | 26.92 | $0.51 | 52.86 |
2015-04-30 | 26.55 | $0.41 | 64.05 |
2015-01-31 | 28.76 | $0.28 | 102.06 |
2014-10-31 | 29.78 | $0.69 | 43.07 |
2014-07-31 | 23.80 | $0.63 | 37.52 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $37.687B | $2.747B |
Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $9.349B | 0.00 |
Hims & Hers Health (HIMS) | United States | $7.785B | 125.14 |
Inspire Medical Systems (INSP) | United States | $4.759B | 92.44 |
IRhythm Technologies (IRTC) | United States | $3.404B | 0.00 |
Privia Health (PRVA) | United States | $2.840B | 212.82 |
Enovis (ENOV) | United States | $1.994B | 12.34 |
Schrodinger (SDGR) | United States | $1.883B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.763B | 0.00 |
Omnicell (OMCL) | United States | $1.471B | 31.72 |
Phreesia (PHR) | United States | $1.461B | 0.00 |
Azenta (AZTA) | United States | $1.216B | 56.62 |
10x Genomics (TXG) | United States | $1.025B | 0.00 |
Butterfly Network (BFLY) | United States | $0.583B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
Talkspace (TALK) | United States | $0.532B | 316.00 |
Veradigm (MDRX) | United States | $0.457B | 0.00 |
Standard BioTools (LAB) | United States | $0.440B | 0.00 |
TruBridge (TBRG) | United States | $0.389B | 0.00 |
Claritev (CTEV) | United States | $0.373B | 0.00 |
Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
Pulmonx (LUNG) | United States | $0.212B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
American Well (AMWL) | United States | $0.114B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
CareCloud (CCLD) | United States | $0.077B | 3.31 |
111 (YI) | China | $0.072B | 0.00 |
P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
HeartBeam (BEAT) | United States | $0.061B | 0.00 |
Outset Medical (OM) | United States | $0.041B | 0.00 |
Zepp Health (ZEPP) | China | $0.040B | 0.00 |
Zhongchao (ZCMD) | China | $0.028B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
Movano (MOVE) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |